全文获取类型
收费全文 | 59篇 |
免费 | 4篇 |
专业分类
儿科学 | 1篇 |
基础医学 | 9篇 |
临床医学 | 1篇 |
内科学 | 12篇 |
皮肤病学 | 1篇 |
神经病学 | 4篇 |
特种医学 | 9篇 |
外科学 | 9篇 |
预防医学 | 6篇 |
药学 | 2篇 |
肿瘤学 | 9篇 |
出版年
2021年 | 1篇 |
2017年 | 2篇 |
2016年 | 1篇 |
2015年 | 1篇 |
2014年 | 1篇 |
2013年 | 2篇 |
2012年 | 2篇 |
2009年 | 2篇 |
2008年 | 1篇 |
2007年 | 3篇 |
2006年 | 3篇 |
2005年 | 7篇 |
2004年 | 3篇 |
2003年 | 1篇 |
2002年 | 7篇 |
2001年 | 2篇 |
2000年 | 1篇 |
1998年 | 1篇 |
1997年 | 2篇 |
1996年 | 2篇 |
1995年 | 5篇 |
1992年 | 3篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1986年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1975年 | 1篇 |
1972年 | 1篇 |
1971年 | 1篇 |
1967年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有63条查询结果,搜索用时 0 毫秒
61.
Breast Cancer After Augmentation Mammoplasty 总被引:5,自引:0,他引:5
Skinner KA Silberman H Dougherty W Gamagami P Waisman J Sposto R Silverstein MJ 《Annals of surgical oncology》2001,8(2):138-144
Background:It is thought that implants interfere with breast cancer diagnosis and that cancers in women who have had breast augmentation carry a worse prognosis.Methods:A prospective breast cancer database was reviewed, comparing augmented and nonaugmented patients for details of histology, palpability, tumor size, nodal status, mammographic status, receptor status, nuclear grade, stage, and outcome.Results:Ninety-nine cancers in augmented women and 2857 cancers in nonaugmented women were identified. Among these women, mammography was normal in 43% of those who had had augmentation and in 5% of those who had not. Augmented women were more likely to have palpable cancers (83% vs. 59%) and nodal involvement (48% vs. 36%), and less likely to have ductal carcinoma in situ (DCIS) (18% vs. 28%). When comparing only women younger than 50, the differences in invasiveness and nodal status lost significance. Cancers diagnosed in the 1990s were more likely to be nonpalpable and noninvasive than those diagnosed in the 1980s. This trend was more pronounced in the augmented population.Conclusions:Augmented patients were more likely to have palpable cancers, although the overall stage and outcome were similar to those of nonaugmented women. Although there have been significant improvements in our ability to diagnose early breast cancer over the past two decades, mammography continues to be suboptimal in augmented women.Presented at the 53rd Annual Meeting of the Society of Surgical Oncology, New Orleans, Louisiana, March 16-19, 2000 相似文献
62.
Ariatti C Vivenza D Capello D Migliazza A Parvis G Fassone L Buonaiuto D Savinelli F Rossi D Saglio G Gaidano G 《Human pathology》2000,31(7):871-873
Common-variable immunodeficiency (CVI) patients develop non-Hodgkin's lymphomas (NHL), mainly B-lineage diffuse large-cell lymphomas (DLCL), with a high relative risk. The molecular pathogenesis of CVI-related NHL (CVI-NHL) is unknown. Here we aimed at providing a detailed molecular characterization of CVI-NHL. Rearrangements of BCL-6 were detected in two thirds of CVI-NHL cases examined. All 3 CVI-NHL also harbored point mutations of the BCL-6 5' noncoding regions, which constitute a marker of B-cell transit through the germinal center (GC). The number and molecular pattern of BCL-6 mutations in CVI-NHL were similar to that detected in DLCL of immunocompetent hosts and in DLCL arising in other immunodeficiency settings. Microsatellite instability occurred in one CVI-NHL devoid of a BCL-6 rearrangement. All CVI-NHL scored negative for genetic lesions of BCL-2, p53, c-MYC, REL as well as for viral infection by EBV and HHV-8. Overall, these data indicate that: similarly to other immunodeficiency-related NHL, involvement of BCL6 occurs frequently also in CVI-NHL; and because BCL-6 mutations are acquired by B cells during GC transit, their occurrence in CVI-NHL suggest that these lymphomas are histogenetically related to GC B cells. 相似文献
63.
Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders
Cristina Pastore Josep Nomdedeu Gisella Volpe Angelo Guerrasio Giovanna Rege Cambrin Guido Parvis Marisa Pautasso Cristiano Daglio Umberto Mazza Giuseppe Saglio Gianluca Gaidano 《Genes, chromosomes & cancer》1995,14(2):106-111
Chromosomal deletions of band 13q14 occur recurrently in BCR/ABL negative chronic myeloproliferative disorders (CMPD), including myelosclerosis with myeloid metaplasia (MMM), polycythemia vera (PV), essential thrombocythemia (ET), juvenile chronic myeloid leukemia (JCML), and the so-called BCR/ABL ? chronic myeloid leukemia (CML). The RB1 tumor suppressor locus, mapping to 13q14, has long since been hypothesized as the important gene. In this report, we have determined the frequency of 13q14 deletions at the molecular level in a large panel of BCR/ABL ? CMPD at different disease stages and performed a detailed genetic analysis of gross rearrangements/deletions and point mutations of the RBI gene in these disorders. Our data show that molecular deletions of 13q14 are detected in a relatively large fraction of BCR/ABL ? CMPD (38%), that they appear to be more frequent in MMM than in other BCR/ABL ? CMPD, and that they may be present at diagnosis or occur during blastic evolution of the neoplasia. The RBI gene displayed a germline configuration in all BCR/ABL ? CMPD tested, suggesting that 13q14 deletions in these disorders affect a tumor suppressor locus distinct from RB1. 相似文献